William Blair Brokers Boost Earnings Estimates for ARCT
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) – Equities researchers at William Blair lifted their Q2 2025 EPS estimates for Arcturus Therapeutics in a research report issued to clients and investors on Tuesday, May 13th. William Blair analyst M. Minter now expects that the biotechnology company will earn ($0.70) per share for the quarter, […]
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) – Equities researchers at William Blair lifted their Q2 2025 EPS estimates for Arcturus Therapeutics in a research report issued to clients and investors on Tuesday, May 13th. William Blair analyst M. Minter now expects that the biotechnology company will earn ($0.70) per share for the quarter, […]
